Oxygen supply for tissue engineering

Engineering Biomaterials for Regenerative Medicine: Novel Technologies for Clinical Applications

Volumn , Issue , 2012, Pages 41-86

  Stoppel, Whitney L ^a   Roberts, Susan C ^a  

^a University of Massachusetts   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSELS; CELL DEATH; CELL PROLIFERATION; SCAFFOLDS (BIOLOGY); TISSUE;

BIOLOGICAL PROCESS; BLOOD VESSEL GROWTH; CELLULAR BEHAVIORS; ENGINEERED DEVICES; LOW OXYGEN TENSIONS; PROLIFERATION AND APOPTOSIS; TISSUE ENGINEERED CONSTRUCTS; TISSUE-ENGINEERED SCAFFOLDS;

OXYGEN SUPPLY;

EID: 84872677908     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-1080-5_3     Document Type: Chapter

References (285)

1. Khattak, S.F., Chin, K.S., Bhatia, S.R., Roberts, S.C.: Enhancing oxygen tension and cellular function in alginate cell encapsulation devices through the use of perfluorocarbons. Biotechnol. Bioeng. 96(1), 156-166 (2007)
2. Arifin, D.R., Palmer, A.F.: Polymersome encapsulated hemoglobin: a novel type of oxygen carrier. Biomacromolecules 6(4), 2172-2181 (2005)
3. Harrison, B.S., Eberli, D., Lee, S.J., Atala, A., Yoo, J.J.: Oxygen producing biomaterials for tissue regeneration. Biomaterials 28(31), 4628-4634 (2007)
4. Oh, S.H., Ward, C.L., Atala, A., Yoo, J.J., Harrison, B.S.: Oxygen generating scaffolds for enhancing engineered tissue survival. Biomaterials 30(5), 757-762 (2009)
5. Laschke, M.W., Harder, Y., Amon, M., Martin, I., Farhadi, J., Ring, A., et al.: Angiogenesis in tissue engineering: Breathing life into constructed tissue substitutes. Tissue Eng. 12(8), 2093-2104 (2006)
6. Santos, M.I., Reis, R.L.: Vascularization in bone tissue engineering: physiology, current strategies, major hurdles and future challenges. Macromol. Biosci. 10(1), 12-27 (2010)
7. Semenza, G.L.: Regulation of mamalian O homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol. 15(1), 551-578 (1999)
8. Jiang, B.H., Semenza, G.L., Bauer, C., Marti, H.H.: Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O tension. AJP - Cell Physiol. 271(4), C1172-C1180 (1996)
9. Iyer, N.V., Kotch, L.E., Agani, F., Leung, S.W., Laughner, E., Wenger, R.H., et al.: Cellular and developmental control of O homeostasis by hypoxia-inducible factor 1a. Genes Dev. 12(2), 149-162 (1998)
10. Wang, G.L., Semenza, G.L.: General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc. Natl. Acad. Sci. USA 90(9), 4304-4308 (1993)
11. Reynolds, T.Y., Rockwell, S., Glazer, P.M.: Genetic instability induced by the tumor microenvironment. Cancer Res. 56(24), 5754-5757 (1996)
12. Malda, J., Rouwkema, J., Martens, D.E., le Comte, E.P., Kooy, F.K., Tramper, J., et al.: Oxygen gradients in tissue-engineered PEGT/PBT cartilaginous constructs: Measurement and modeling. Biotechnol. Bioeng. 86(1), 9-18 (2004)
13. Radisic, M., Malda, J., Epping, E., Geng, W., Langer, R., Vunjak-Novakovic, G.: Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol. Bioeng. 93(2), 332-343 (2006)
14. Malda, J., Klein, T.J., Upton, Z.: The roles of hypoxia in the in vitro engineering of tissues. Tissue Eng. 13(9), 2153-2162 (2007)
15. Kellner, K., Liebsch, G., Klimant, I., Wolfbeis, O.S., Blunk, T., Schulz, M.B., et al.: Determination of oxygen gradients in engineered tissue using a fluorescent sensor. Biotechnol. Bioeng. 80(1), 73-83 (2002)
16. Galban, C.J., Locke, B.R.: Effects of spatial variation of cells and nutrient and product concentrations coupled with product inhibition on cell growth in a polymer scaffold. Biotechnol. Bioeng. 64(6), 633-643 (1999)
17. Johnson, A.S., Fisher, R.J., Weir, G.C., Colton, C.K.: Oxygen consumption and diffusion in assemblages of respiring spheres: Performance enhancement of a bioartificial pancreas. Chem. Eng. Sci. 64(22), 4470-4487 (2009)
18. Croll, T.I., Gentz, S., Mueller, K., Davidson, M., O&’Connor, A.J., Stevens, G.W., et al.: Modelling oxygen diffusion and cell growth in a porous, vascularising scaffold for soft tissue engineering applications. Chem. Eng. Sci. 60(17), 4924-4934 (2005)
19. Landman, K., Cai, A.: Cell proliferation and oxygen diffusion in a vascularising scaffold. Bull. Math. Biol.69(7), 2405-2428 (2007)
20. Griffith, L.G., Naughton, G.: Tissue engineering - Current challenges and expanding opportunities. Science 295(5557), 1009-1014 (2002)
21. Taylor, C., Pouyssegur, J.: Oxygen, hypoxia, and stress. Ann. N. Y. Acad. Sci. 1113(1), 87-94 (2007)
22. Semenza, G.L.: Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3(10), 721-732 (2003)
23. Greijer, A., Van der Wall, E.: The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J. Clin. Pathol. 57(10), 1009-1014 (2004)
24. Bunn, H.F., Poyton, R.O.: Oxygen sensing and molecular adaptation to hypoxia. Physiol. Rev. 76(3), 839-885 (1996)
25. Huang, L.E., Gu, J., Schau, M., Bunn, H.F.: Regulation of hypoxia-inducible factor 1a is mediated by an O-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl Acad. Sci. USA 95(14), 7987-7992 (1998)
26. Krieg, M., Haas, R., Brauch, H., Acker, T., Flamme, I., Plate, K.: Up-regulation of hypoxia- inducible factors HIF-1 and HIF-2 under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene 19(48), 5435-5443 (2000)
27. Bruick, R.K., McKnight, S.L.: A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294(5545), 1337-1340 (2001)
28. Schipani, E., Ryan, H.E., Didrickson, S., Kobayashi, T., Knight, M., Johnson, R.S.: Hypoxia in cartilage: HIF-1a is essential for chondrocyte growth arrest and survival. Genes Dev. 15(21), 2865-2876 (2001)
29. Guillemin, K., Krasnow, M.A.: The hypoxic response: Huffing and HIFing. Cell 89(1), 9-12 (1997)
30. Raval, R.R., Lau, K.W., Tran, M.G.B., Sowter, H.M., Mandriota, S.J., Li, J.-L., et al.: Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel- Lindau-associated renal cell carcinoma. Mol. Cell. Biol. 25(13), 5675-5686 (2005)
31. Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., et al.: Role of HIF-1a in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394(6692), 485-490 (1998)
32. Moritz, W., Meier, F., Stroka, D., Giuliani, M., Kugelmeier, P., Nett, P.C., et al.: Apoptosis in hypoxic human pancreatic islets correlates with HIF-1 a expression. FASEB J. 16, 745-747 (2002). doi:01-0403fje
33. Chen, J., Zhao, S., Nakada, K., Kuge, Y., Tamaki, N., Okada, F., et al.: Dominant-negative hypoxia-inducible factor-1a reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism. Am. J. Pathol. 162(4), 1283-1291 (2003)
34. Kvietikova, I., Wenger, R.H., Marti, H.H., Gassmann, M.: The transcription factors ATF-1 and CREB-1 bind constitutively to the hypoxia-inducible factor-1 (HIF-1) DNA recognition site. Nucleic Acids Res. 23(22), 4542-4550 (1995)
35. Wang, G.L., Semenza, G.L.: Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 268(29), 21513-21518 (1993)
36. Gassmann, M., Fandrey, J., Bichet, S., Wartenberg, M., Marti, H.H., Bauer, C., et al.: Oxygen supply and oxygen-dependent gene expression in differentiating embryonic stem cells. Proc. Natl Acad. Sci. USA 93(7), 2867-2872 (1996)
37. Lim, J.-H., Chun, Y.-S., Park, J.-W.: Hypoxia-inducible factor-1a obstructs a Wnt signaling pathway by inhibiting the hARD1-mediated activation of b-catenin. Cancer Res. 68(13), 5177-5184 (2008)
38. Kaufman, D.S.: HIF hits Wnt in the stem cell niche. Nat. Cell Biol. 12(10), 926-927 (2010)
39. Bijlsma, M.F., Groot, A.P., Oduro, J.P., Franken, R.J., Schoenmakers, S.H.H.F., Peppelenbosch, M.P., et al.: Hypoxia induces a hedgehog response mediated by HIF-1a. J. Cell. Mol. Med. 13(8), 2053-2060 (2009)
40. Covello, K.L., Kehler, J., Yu, H., Gordan, J.D., Arsham, A.M., Hu, C.-J., et al.: HIF- 2a regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev. 20(5), 557-570 (2006)
41. Chen, R., Silva, E., Yuen, W., Mooney, D.: Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm. Res. 24(2), 258-264 (2007)
42. Pugh, C., Ratcliffe, P.: Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9(6), 677-684 (2003)
43. Lee, K., Mooney, D.: Hydrogels for tissue engineering. Chem. Rev. 101(7), 1869-1880 (2001)
44. Ennett, A.B., Mooney, D.J.: Tissue engineering strategies for in vivo neovascularisation. Expert Opin. Ther. 2(8), 805-818 (2002)
45. Mieszawska, A., Kaplan, D.: Smart biomaterials - regulating cell behavior through signaling molecules. BMC Biol. 8(1), 59 (2010)
46. Halterman, M.W., Miller, C.C., Federoff, H.J.: Hypoxia-inducible factor-1a mediates hypoxia- induced delayed neuronal death that involves p53. J. Neurosci. 19(16), 6818-6824 (1999)
47. Kothari, S., Cizeau, J., McMillan-Ward, E., Israels, S.J., Bailes, M., Ens, K., et al.: BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF. Oncogene 22(30), 4734-4744 (2000)
48. Young, S.D., Marshall, R.S., Hill, R.P.: Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc. Natl Acad. Sci. USA 85(24), 9533-9537 (1988)
49. Coquelle, A., Toledo, F., Stern, S., Bieth, A., Debatisse, M.: A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs. Mol. Cell 2(2), 259-265 (1998)
50. Bencokova, Z., Kaufmann, M.R., Pires, I.M., Lecane, P.S., Giaccia, A.J., Hammond, E.M.: ATM activation and signaling under hypoxic conditions. Mol. Cell. 29(2), 526-537 (2009)
51. Zhu, W., Chen, J., Cong, X., Hu, S., Chen, X.: Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells 24(2), 416-425 (2006)
52. Saikumar, P., Dong, Z., Patel, Y., Hall, K., Hopfer, U., Weinberg, J., et al.: Role of hypoxia- induced Bax translocation and cytochrome c release in reoxygenation injury. Oncogene 17(26), 3401-3415 (1998)
53. Boutilier, R.G., St-Pierre, J.: Surviving hypoxia without really dying. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 126(4), 481-490 (2000)
54. Henrotin, Y.E., Bruckner, P., Pujol, J.P.L.: The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage 11(10), 747-755 (2003)
55. Kim, J.-Y., Park, J.-H.: ROS-dependent caspase-9 activation in hypoxic cell death. FEBS Lett. 549(1), 94-98 (2003)
56. Kunz, M., Ibrahim, S., Koczan, D., Thiesen, H., Kohler, H., Acker, T., et al.: Activation of c- Jun NH2-terminal kinase/stress-activated protein kinase (JNK/SAPK) is critical for hypoxia- induced apoptosis of human malignant melanoma. Cell Growth Differ. 12(3), 137-145 (2001)
57. Tibbles, L.A., Woodgett, J.R.: The stress-activated protein kinase pathways. Cell. Mol. Life Sci. 55(10), 1230-1254 (1999)
58. Lovett, M., Lee, K., Edwards, A., Kaplan, D.: Vascularization strategies for tissue engineering. Tissue Eng. Part B Rev. 15(3), 353-370 (2009)
59. Goosen, M.F.A.: Fundamentals of Animal Cell Encapsulation and Immobilization. CRC, Boca Raton (1993)
60. Poncelet, D., Bugarski, B., Amsden, B.G., Zhu, J., Neufeld, R., Goosen, M.F.A.: A parallelplate electrostatic droplet generator - parameters affecting microbead size. Appl. Microbiol. Biotechnol. 42(2), 251-255 (1994)
61. Strand, B.L., Gaserod, O., Kulseng, B., Espevik, T., Skjak-Braek, G.: Alginate-polylysine- alginate microcapsules: Effect of size reduction on capsule properties. J. Microencapsul. 19(5), 615-630 (2002)
62. Klokk, T.I., Melvik, J.E.: Controlling the size of alginate gel beads by use of a high electrostatic potential. J. Microencapsul. 19(4), 415-424 (2002)
63. Sakai, S., Hashimoto, I., Kawakami, K.: Development of alginate-agarose subsieve-size capsules for subsequent modification with a polyelectrolyte complex membrane. Biochem. Eng. J. 30(1), 76-81 (2006)
64. Agrawal, C.M., Ray, R.B.: Biodegradable polymeric scaffolds for musculoskeletal tissue engineering. J. Biomed. Mater. Res. 55(2), 141-150 (2001)
65. Lim, F., Sun, A.M.: Microencapsulated islets as bioartificial endocrine pancreas. Science 210(4472), 908-910 (1980)
66. Fu, X.W., Sun, A.M.: Microencapsulated parathyroid cells as a bioartificial parathyroid- in vivo studies. Transplantation 47(3), 432-435 (1989)
67. Cieslinski, D.A., Humes, H.D.: Tissue engineering of a bioartificial kidney. Biotechnol. Bioeng. 43(7), 678-681 (1994)
68. de Vos, P., Bucko, M., Gemeiner, P., Navratil, M., Svitel, J., Faas, M., et al.: Multiscale requirements for bioencapsulation in medicine and biotechnology. Biomaterials 30(13), 2559-2570 (2009)
69. Hernandez, R.M., Orive, G., Murua, A., Pedraz, J.L.: Microcapsules and microcarriers for in situ cell delivery. Adv. Drug Deliv. Rev. 62(7), 711-730 (2010)
70. Hay, P.D., Veitch, A.R., Smith, M.D., Cousins, R.B., Gaylor, J.D.S.: Oxygen transfer in a diffusion-limited hollow fiber bioartificiala liver. Artif. Organs 24(4), 278-288 (2000)
71. Yu, P., Zeng, Y., Lee, T.S., Low, H.T.: Anumerical analysis of cell density effect on oxygen transport in a micro-bioreactor with a tissue engineering scaffold. Int. Commun. Heat Mass Transfer 36(6), 569-573 (2009)
72. Chin, K., Khattak, S.F., Bhatia, S.R., Roberts, S.C.: Hydrogel-perfluorocarbon composite scaffold promotes oxygen transport to immobilized cells. Biotechnol. Prog. 24(2), 358-366 (2008)
73. Valentin, J.E., Freytes, D.O., Grasman, J.M., Pesyna, C., Freund, J., Gilbert, T.W., et al.: Oxygen diffusivity of biologic and synthetic scaffold materials for tissue engineering. J. Biomed. Mater. Res. A 91(4), 1010-1017 (2009)
74. Radisic, M., Deen, W., Langer, R., Vunjak-Novakovic, G.: Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am. J. Physiol. Heart Circ. Physiol. 288(3), H1278-H1289 (2005)
75. Acosta, M.A., Ymele-Leki, P., Kostov, Y.V., Leach, J.B.: Fluorescent microparticles for sensing cell microenvironment oxygen levels within 3D scaffolds. Biomaterials 30(17), 3068-3074 (2009)
76. Mishra, A., Starly, B.: Real time in vitro measurement of oxygen uptake rates for HEPG2 liver cells encapsulated in alginate matrices. Microfluid. Nanofluidics 6(3), 373-381 (2009)
77. Kino-oka, M., Kagita, S., Nadzir, M.M., Inoue, H., Sugawara, K., Taya, M.: Direct measurement of oxygen concentration inside cultured cartilage for relating to spatial growth of rabbit chondrocytes. J. Biosci. Bioeng. 110(3), 363-366 (2010)
78. Terai, S., Tsujimura, T., Li, S., Hori, Y., Toyama, H., Shinzeki, M., et al.: Effect of oxygenated perfluorocarbon on isolated islets during transportation. J. Surg. Res. 162(2), 284-289 (2010)
79. Chen, G., Palmer, A.F.: Mixtures of hemoglobin-based oxygen carriers and perfluorocarbons exhibit a synergistic effect in oxygenating hepatic hollow fiber bioreactors. Biotechnol. Bioeng. 105(3), 534-542 (2010)
80. Brown, D.A., MacLellan, W.R., Laks, H., Dunn, J.C.Y., Wu, B.M., Beygui, R.E.: Analysis of oxygen transport in a diffusion-limited model of engineered heart tissue. Biotechnol. Bioeng. 97(4), 962-975 (2007)
81. Kimelman-Bleich, N., Pelled, G., Sheyn, D., Kallai, I., Zilberman, Y., Mizrahi, O., et al.: The use of a synthetic oxygen carrier-enriched hydrogel to enhance mesenchymal stem cell-based bone formation in vivo. Biomaterials [Article] 30(27), 4639-4648 (2009)
82. Lowe, K.C., Davey, M.R., Power, J.B.: Perfluorochemicals: their applications and benefits to cell culture. Trends Biotechnol. 16(6), 272-277 (1998)
83. Peng, C.C., Kim, J., Chauhan, A.: Extended delivery of hydrophilic drugs from siliconehydrogel contact lenses containing Vitamin E diffusion barriers. Biomaterials 31(14), 4032-4047 (2010)
84. Stoppel, W.L., White, J.C., Horava, S.D., Bhatia, S.R., Roberts, S.C.: Transport of biological molecules in surfactant-alginate composite hydrogels. Acta Biomaterialia. In Press, Accepted Manuscript
85. Demol, J., Lambrechts, D., Geris, L., Schrooten, J., Van Oosterwyck, H.: Towards a quantitative understanding of oxygen tension and cell density evolution in fibrin hydrogels. Biomaterials 32(1), 107-118 (2011)
86. Wood, B.D., Quintard, M., Whitaker, S.: Calculation of effective diffusivities for biofilms and tissues. Biotechnol. Bioeng. 77(5), 495-516 (2002)
87. Rumsey, W.L., Schlosser, C., Nuutinen, E.M., Robiolio, M., Wilson, D.F.: Cellular energetics and the oxygen dependence of respiration in cardiac myocytes isolated from adult rat. J. Chem. 265(26), 15392-15402 (1990)
88. Xiong, Y., Xu, J., Zhu, D-q, Duan, C-f, Guan, Y-f: Fiber-optic fluorescence sensor for dissolved oxygen detection based on fluorinated xerogel immobilized with ruthenium (II) complex. J. Sol-Gel Sci. Technol. 53(2), 441-447 (2010)
89. Bellucci, J.J., Hamaker, K.H.: Evaluation of oxygen transfer rates in stirred-tank bioreactors for clinical manufacturing. Biotechnol. Prog. 27(2), 368-376 (2011)
90. Suresh, S., Srivastava, V.C., Mishra, I.M.: Techniques for oxygen transfer measurement in bioreactors: a review. J. Chem. Technol. Biotechnol. 84(8), 1091-1103 (2009)
91. Niebruegge, S., Bauwens, C.L., Peerani, R., Thavandiran, N., Masse, S., Sevaptisidis, E., et al.: Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor. Biotechnol. Bioeng. 102(2), 493-507 (2009)
92. Volkmer, E., Drosse, I., Otto, S., Stangelmayer, A., Stengele, M., Kallukalam, B.C., et al.: Hypoxia in static and dynamic 3D culture systems for tissue engineering of bone. Tissue Eng. Part A 14(8), 1331-1340 (2008)
93. Janssen, F.W., Oostra, J., Oorschot, Av, van Blitterswijk, C.A.: A perfusion bioreactor system capable of producing clinically relevant volumes of tissue-engineered bone: In vivo bone formation showing proof of concept. Biomaterials 27(3), 315-323 (2006)
94. Picioreanu, C., van Loosdrecht, Heijnen, J.J.: A new combined differential-discrete cellular automaton approach for biofilm modeling: Application for growth in gel beads. Biotechnol. Bioeng. 57(6), 718-731 (1998)
95. Shuler, M., Kargi, F.: Bioprocess Engineering. Prentice Hall Upper Saddle River, NJ (2002)
96. Cassell, O.C.S., Morrison, W.A., Messina, A., Penington, A.J., Thompson, E.W., Stevens, G. W., et al.: The influence of extracellular matrix on the generation of vascularized, engineered, transplantable tissue. Ann. N. Y. Acad. Sci. 944(1), 429-442 (2001)
97. Vunjak-Novakovic, G., Obradovic, B., Martin, I., Bursac, P.M., Langer, R., Freed, L.E.: Dynamic cell seeding of polymer scaffolds for cartilage tissue engineering. Biotechnol. Prog. 14(2), 193-202 (1998)
98. Discher, D.E., Mooney, D.J., Zandstra, P.W.: Growth factors, matrices, and forces combine and control stem cells. Science 324(5935), 1673-1677 (2009)
99. Clark, L.C.J.R., Wolf, R., Granger, D., Taylor, Z.: Continuous recording of blood oxygen tensions by polarography. J. Appl. Physiol. 6(3), 189-193 (1953)
100. Androjna, C., Gatica, J., Belovich, J., Derwin, K.: Oxygen diffusion through natural extracellular matrices: Implications for estimating critical thickness&” values in tendon tissue engineering. Tissue Eng. Part A 14(4), 559-569 (2008)
101. Strickland, J.D.H., Parsons, T.R., Fisheries Research Board of Canada: A Practical Handbook of Seawater Analysis, 2nd edn. Fisheries Research Board of Canada, Ottawa (1972)
102. Koo, Y.-E.L., Cao, Y., Kopelman, R., Koo, S.M., Brasuel, M., Philbert, M.A.: Real-time measurements of dissolved oxygen inside live cells by organically modified silicate fluorescent nanosensors. Anal. Chem. 76(9), 2498-2505 (2004)
103. Choi, N.W., Cabodi, M., Held, B., Gleghorn, J.P., Bonassar, L.J., Stroock, A.D.: Microfluidic scaffolds for tissue engineering. Nat. Mater. 6(11), 908-915 (2007)
104. Oppegard, S.C., Blake, A.J., Williams, J.C., Eddington, D.T.: Precise control over the oxygen conditions within the Boyden chamber using a microfabricated insert. Lab Chip 10(18), 2366-2373 (2010)
105. Ishaug, S.L., Crane, G.M., Miller, M.J., Yasko, A.W., Yaszemski, M.J., Mikos, A.G.: Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J. Biomed. Mater. Res. 36(1), 17-28 (1997)
106. Laurencin, C.T., Attawia, M.A., Elgendy, H.E., Herbert, K.M.: Tissue engineered bone- regeneration using degradable polymers: The formation of mineralized matrices. Bone 19(1), 93-99 (1996)
107. Burg, K.J.L., Porter, S., Kellam, J.F.: Biomaterial developments for bone tissue engineering. Biomaterials 21(23), 2347-2359 (2000)
108. Ma, P.X., Zhang, R., Xiao, G., Franceschi, R.: Engineering new bone tissue in vitro on highly porous poly(a-hydroxyl acids)/hydroxyapatite composite scaffolds. J. Biomed. Mater. Res. 54(2), 284-293 (2001)
109. Pisu, M., Lai, N., Cincotti, A., Concas, A., Cao, G.: Modeling of engineered cartilage growth in rotating bioreactors. Chem. Eng. Sci. 59(22-23), 5035-5040 (2004)
110. Grande, D.A., Halberstadt, C., Naughton, G., Schwartz, R., Manji, R.: Evaluation of matrix scaffolds for tissue engineering of articular cartilage grafts. J. Biomed. Mater. Res. 34(2), 211-220 (1997)
111. Chromiak, J., Shansky, J., Perrone, C., Vandenburgh, H.: Bioreactor perfusion system for the long-term maintenance of tissue-engineered skeletal muscle organoids. In Vitro Cell. Dev. Anim.34(9), 694-703 (1998)
112. Jeong, S.I., Kwon, J.H., Lim, J.I., Cho, S.-W., Jung, Y., Sung, W.J., et al.: Mechano-active tissue engineering of vascular smooth muscle using pulsatile perfusion bioreactors and elastic PLCL scaffolds. Biomaterials 26(12), 1405-1411 (2005)
113. Carrier, R.L., Rupnick, M., Langer, R., Schoen, F.J., Freed, L.E., Vunjak-Novakovic, G.: Effects of oxygen on engineered cardiac muscle. Biotechnol. Bioeng. 78(6), 617-625 (2002)
114. Brown, D.A., MacLellan, W.R., Dunn, J.C.Y., Wu, B.M., Beygui, R.E.: Hypoxic cell death is reduced by pH buffering in a model of engineered heart tissue. Artif. Cells Blood Substit. Immobil. Biotechnol. 36(2), 94-113 (2008)
115. Nieuwoudt, M.J., Moolman, S.F., Van Wyk, K.J., Kreft, E., Olivier, B., Laurens, J.B., et al.: Hepatocyte function in a radial-flow bioreactor using a perfluorocarbon oxygen carrier. Artif. Organs 29(11), 915-918 (2005)
116. Nieuwoudt, M., Wiggett, S., Malfeld, S., van der Merwe, S.: Imaging glucose metabolism in perfluorocarbon-perfused hepatocyte bioreactors using positron emission tomography. J. Artif. Organs 12(4), 247-257 (2009)
117. Gordon, J.E., Dare, M.R., Palmer, A.F.: Engineering select physical properties of cross- linked red blood cells and a simple a priori estimation of their efficacy as an oxygen delivery vehicle within the context of a hepatic hollow fiber bioreactor. Biotechnol. Prog. 21(6), 1700-1707 (2005)
118. Zhao, F., Chella, R., Ma, T.: Effects of shear stress on 3-D human mesenchymal stem cell construct development in a perfusion bioreactor system: Experiments and hydrodynamic modeling. Biotechnol. Bioeng. 96(3), 584-595 (2007)
119. Datta, N., Pham, Q.P., Sharma, U., Sikavitsas, V.I., Jansen, J.A., Mikos, A.G.: In vitro generated extracellular matrix and fluid shear stress synergistically enhance 3D osteoblastic differentiation. Proc. Natl Acad. Sci. USA 103(8), 2488-2493 (2006)
120. Holtorf, H.L., Jansen, J.A., Mikos, A.G.: Flow perfusion culture induces the osteoblastic differentiation of marrow stromal cell-scaffold constructs in the absence of dexamethasone. J. Biomed. Mater. Res. A 72(3), 326-334 (2005)
121. Riess, J.G.: Perfluorocarbon-based oxygen delivery. Artif. Cells Blood Substit. Immobil. Biotechnol. 34(6), 567-580 (2006)
122. Riess, J.G.: Oxygen carriers (&“blood substitutes&”) - Raison d&’Etre, chemistry, and some physiology. Chem. Rev. 101(9), 2797-2919 (2001)
123. Phillips, W.T., Goins, B., Klipper, R., Cook, B.G., Martin, C., Lemen, L., et al.: Tissue oxygen delivery and tissue distribution of liposome encapsulated hemoglobin. In: Eishun, T. (ed.) Blood Substitutes, Present and Future Perspectives, pp. 147-160. Elsevier Science, Lausanne (1998)
124. Sakai, H., Tomiyama, K-i, Sou, K., Takeoka, S., Tsuchida, E.: Poly(ethylene glycol)-conju- gation and deoxygenation enable long-term preservation of hemoglobin-vesicles as oxygen carriers in a liquid state. Bioconjug. Chem. 11(3), 425-432 (2000)
125. Phillips, W.T., Klipper, R.W., Awasthi, V.D., Rudolph, A.S., Cliff, R., Kwasiborski, V., et al.: Polyethylene glycol-modified liposome-encapsulated hemoglobin: A long circulating red cell substitute. J. Pharmacol. Exp. Ther. 288(2), 665-670 (1999)
126. Sakai, H., Takeoka, S., Park, S.I., Kose, T., Nishide, H., Izumi, Y., et al.: Surface modification of hemoglobin vesicles with poly(ethylene glycol) and effects on aggregation, viscosity, and blood flow during 90 exchange transfusion in anesthetized rats. Bioconjug. Chem. 8(1), 23-30 (1997)
127. Usuba, A., Osuka, F., Kimura, T., Sato, R., Ogata, Y., Gotoh, H., et al.: Effect of liposome- encapsulated hemoglobin, neo red cells, on hemorrhagic shock. Surg. Today 28(10), 1027-1035 (1998)
128. Takahashi, A.: Characterization of neo red cells (NRCs), their function and safety in vivo tests. Artif. Cells Blood Substit. Immobil.Biotechnol. 23(3), 347-354 (1995)
129. Li, S., Nickels, J., Palmer, A.F.: Liposome-encapsulated actin-hemoglobin (LEAcHb) artificial blood substitutes. Biomaterials 26(17), 3759-3769 (2005)
130. Discher, B.M., Bermudez, H., Hammer, D.A., Discher, D.E., Won, Y.-Y., Bates, F.S.: Cross- linked polymersome membranes: vesicles with broadly adjustable properties. J. Phys. Chem. B 106(11), 2848-2854 (2002)
131. Discher, B.M., Won, Y.-Y., Ege, D.S., Lee, J.C.M., Bates, F.S., Discher, D.E., et al.: Polymersomes: Tough vesicles made from diblock copolymers. Science 284(5417), 1143-1146 (1999)
132. Discher, D.E., Ahmed, F.: Polymersomes. Annu. Rev. Biomed. Eng. 8(1), 323-341 (2006)
133. Rameez, S., Alosta, H., Palmer, A.F.: Biocompatible and biodegradable polymersome encapsulated hemoglobin: A potential oxygen carrier. Bioconjug. Chem. 19(5), 1025-1032 (2008)
134. Riess, J.G.: Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery. Artif. Cells Blood Substit. Immobil. Biotechnol. 33(1), 47-63 (2005)
135. Krafft, M.P., Riess, J.G.: Highly fluorinated amphiphiles and colloidal systems, and their applications in the biomedical field. A contribution. Biochimie 80(5), 489-514 (1998)
136. Kuznetsova, I.N.: Perfluorocarbon emulsions: Stability in vitro and in vivo (A Review). Pharm. Chem. J. 37(8), 415-420 (2003)
137. Fijan, R., Sostar-Turk, S., Lapasin, R.: Rheological study of interactions between non-ionic surfactants and polysaccharide thickeners used in textile printing. Carbohydr. Polym. 68(4), 708-717 (2007)
138. Krafft, M.P., Riess, J.G.: Perfluorocarbons: Life sciences and biomedical uses dedicated to the memory of Professor Guy Ourisson, a true Renaissance man. J. Polym. Sci. A: Polym. Chem. 45(7), 1185-1198 (2007)
139. Gauger, P.G., Pranikoff, T., Schreiner, R.J., Moler, F.W., Hirschl, R.B.: Initial experience with partial liquid ventilation in pediatric patients with the acute respiratory distress syndrome. Crit. Care Med. 24(1), 16-22 (1996)
140. Kin, T., Mirbolooki, M., Salehi, P., Tsukada, M., O&’Gorman, D., Imes, S., et al.: Islet isolation and transplantation outcomes of pancreas preserved with University of Wisconsin solution versus two-layer method using preoxygenated perfluorocarbon. Transplantation 82(10), 1286-1290 (2006)
141. Fraker, C.A., Alvarez, S., Papadopoulos, P., Giraldo, J., Gu, W.Y., Ricordi, C., et al.: Enhanced oxygenation promotes beta-cell differentiation in vitro. Stem Cells 25(12), 3155-3164 (2007)
142. Tan, Q., El-Badry, A.M., Contaldo, C., Steiner, R., Hillinger, S., Welti, M., et al.: The effect of perfluorocarbon-based artificial oxygen carriers on tissue-engineered trachea. Tissue Eng. Part A 15(9), 2471-2480 (2009)
143. MathyHartert, M., Krafft, M.P., Deby, C., DebyDupont, G., Meurisse, M., Lamy, M., et al.: Effects of perfluorocarbon emulsions on cultured human endothelial cells. Artif. Cells Blood Substit. Immobil. Biotechnol. 25(6), 563-575 (1997)
144. Ricordi, C., Fraker, C., Szust, J., Al-Abdullah, I., Poggioli, R., Kirlew, T., et al.: Improved human islet isolation outcome from marginal donors following addition of oxygenated perfluorocarbon to the cold-storage solution. Transplantation 75(9), 1524-1527 (2003)
145. Centis, V., Doillon, C.J., Vermette, P.: (eds). Perfluorocarbon emulsions cytotoxic effects on human fibroblasts and effect of aging on particle size distribution. 9th Vienna International Workshop on Functional Electrical Stimulation; pp. 19-22. Krems, Austria (2007)
146. Ward, C., Haines, N., Patel, R., Eisele, E., Harrison, B.: Assessing angiogenic activity of cells in the presence of oxygen generating biomaterials. FASEB J &23((1_MeetingAbstracts)), 9518(2009)
147. West, J., Moon, J.: Vascularization of engineered tissues: approaches to promote angiogenesis in biomaterials. Curr. Top. Med. Chem. 8(4), 300-310 (2008)
148. Hirschi, K., Skalak, T., Peirce, S., Little, C.: Vascular assembly in natural and engineered tissues. Ann. N. Y. Acad. Sci. 961(Reparative medicine: Growing tissues and organs), 223-242 (2002)
149. Jay, S., Shepherd, B., Andrejecsk, J., Kyriakides, T., Pober, J., Saltzman, W.: Dual delivery of VEGF and MCP-1 to support endothelial cell transplantation for therapeutic vascularization. Biomaterials 31(11), 3054-3062 (2010)
150. Carmeliet, P.: Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6(4), 389-395 (2000)
151. Sun, G., Kusuma, S., Gerecht, S.: The integrated role of biomaterials and stem cells in vascular regeneration. In: Roy, K. (ed.) Biomaterials as Stem Cell Niche, pp. 195-223. Springer, Berlin, Heidelberg (2010)
152. Jain, R.: Molecular regulation of vessel maturation. Nat. Med. 9(6), 685-693 (2003)
153. West, J.L., Hubbell, J.A.: Polymeric biomaterials with degradation sites for proteases involved in cell migration. Macromolecules 32(1), 241-244 (1998)
154. Lutolf, M.P., Hubbell, J.A.: Synthesis and physicochemical characterization of end-linked poly(ethylene glycol)-co-peptide hydrogels formed by Michael-type addition. Biomacromolecules 4(3), 713-722 (2003)
155. Zisch, A.H., Lutolf, M.P., Ehrbar, M., Raeber, G.P., Rizzi, S.C., Davies, N., et al.: Cell- demanded release of VEGF from synthetic, biointeractive cell-ingrowth matrices for vascularized tissue growth. FASEB J. 17(13), 2260-2262 (2003)
156. Kamei, M., Saunders, W.B., Bayless, K.J., Dye, L., Davis, G.E., Weinstein, B.M.: Endothelial tubes assemble from intracellular vacuoles in vivo. Nature 442(7101), 453-456 (2006)
157. Moon, J.J., Saik, J.E., Poche, R.A., Leslie-Barbick, J.E., Lee, S.H., Smith, A.A., et al.: Biomimetic hydrogels with pro-angiogenic properties. Biomaterials 31(14), 3840-3847 (2010)
158. Leslie-Barbick, J., Moon, J., West, J.: Covalently-immobilized vascular endothelial growth factor promotes endothelial cell tubulogenesis in poly (ethylene glycol) diacrylate hydrogels. J. Biomater. Sci. Polym. Ed. 20(12), 1763-1779 (2009)
159. Leslie-Barbick, J.E., Shen, C., Chen, C., West, J.L.: Micron-scale spatially patterned, covalently immobilized vascular endothelial growth factor on hydrogels accelerates endothelial tubulogenesis and increases cellular angiogenic responses. Tissue Eng. Part A 17(1-2), 221-229 (2011)
160. Richardson, T.P., Peters, M.C., Ennett, A.B., Mooney, D.J.: Polymeric system for dual growth factor delivery. Nat. Biotechnol. 19(11), 1029-1034 (2001)
161. Pike, D.B., Cai, S., Pomraning, K.R., Firpo, M.A., Fisher, R.J., Shu, X.Z., et al.: Heparinregulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials 27(30), 5242-5251 (2006)
162. Freeman, I., Cohen, S.: The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization. Biomaterials 30(11), 2122-2131 (2009)
163. Carmeliet, P.: Angiogenesis in life, disease and medicine. Nature 438(7070), 932-936 (2005)
164. Carmeliet, P.: Angiogenesis in life, disease and medicine. &Nat. Biotechnol. 23(1), 47-55 (2005)
165. Carmeliet, P.: Angiogenesis in health and disease. Nat. Med. 9(6), 653-660 (2003)
166. Jay, S.M., Shepherd, B.R., Bertram, J.P., Pober, J.S., Saltzman, W.M.: Engineering of multifunctional gels integrating highly efficient growth factor delivery with endothelial cell transplantation. FASEB J. 22(8), 2949-2956 (2008)
167. Ozawa, C.R., Banfi, A., Glazer, N.L., Thurston, G., Springer, M.L., Kraft, P.E., et al.: Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J. Clin. Invest. 113(4), 516-527 (2004)
168. Wei, G., Jin, Q., Giannobile, W.V., Ma, P.X.: Nano-fibrous scaffold for controlled delivery of recombinant human PDGF-BB. J. Control. Release 112(1), 103-110 (2006)
169. Sahni, A., Sporn, L.A., Francis, C.W.: Potentiation of endothelial cell proliferation by fibrin (ogen)-bound fibroblast growth factor-2. J. Chem. 274(21), 14936-14941 (1999)
170. DeLong, S.A., Moon, J.J., West, J.L.: Covalently immobilized gradients of bFGF on hydrogel scaffolds for directed cell migration. Biomaterials 26(16), 3227-3234 (2005)
171. Refojo, M.F.: Ophthalmological Applications. In: Rattner, B.D., Hoffman, A.S., Schoen, F.J., Lemons, J.E. (eds.) Biomaterials science: An introduction to materials in medicine, 2nd edn, pp. 583-591. Elsevier Academic, San Diego (2004)
172. Holden, B.A., Newton-Howes, J., Winterton, L., Fatt, I., Hamano, H., Hood, D.L., et al.: The Dk project: An interlaboratory comparison of DK/L measurements. Optom. Vis. Sci. 67(6), 476-481 (1990)
173. Peppas, N.A., Yang, W.-H.M.: Properties-based optimization of the structure of polymers for contact lens applications. Eye Contact Lens 7(4), 300-314 (1981)
174. Hong, X.I.N., Himebaugh, N., Thibos, L.N.: On-eye evaluation of optical performance of rigid and soft contact lenses. Optom. Vis. Sci. 78(12), 872-880 (2001)
175. Alvord, L., Court, J., Davis, T., Morgan, C.F., Schindhelm, K., Vogt, J., et al.: Oxygen permeability of a new type of high Dk soft contact lens material. Optom. Vis. Sci. 75(1), 30-36 (1998)
176. Wichterle, O., Lim, D.: Hydrophilic gels for biological use. Nature 185(4706), 117-118 (1960)
177. Ehlers, W., Donshik, P.C.: Update on lotrafilcon A contact lenses. Expert Rev. Ophthalmol. 5, 19-25 (2010)
178. Dillehay, S.M., Miller, M.B.: Performance of lotrafilcon B silicone hydrogel contact lenses in experienced low-Dk/t daily lens wearers. Eye Contact Lens 33(6), 272-277 (2007)
179. Teramura, Y., Iwata, H.: Islet encapsulation with living cells for improvement of biocompatibility. Biomaterials 30(12), 2270-2275 (2009)
180. Schneider, S., Feilen, P.J., Slotty, V., Kampfner, D., Preuss, S., Berger, S., et al.: Multilayer capsules: a promising microencapsulation system for transplantation of pancreatic islets. Biomaterials 22(14), 1961-1970 (2001)
181. de Vos, P., Marchetti, P.: Encapsulation of pancreatic islets for transplantation in diabetes: the untouchable islets. Trends Mol. Med. 8(8), 363-366 (2002)
182. Zimmermann, H., Hillgartner, M., Manz, B., Feilen, P., Brunnenmeier, F., Leinfelder, U., et al.: Fabrication of homogeneously cross-linked, functional alginate microcapsules validated by NMR-, CLSM- and AFM-imaging. Biomaterials 24(12), 2083-2096 (2003)
183. Cheung, C.Y., Anseth, K.S.: Synthesis of immunoisolation barriers that provide localized immunosuppression for encapsulated pancreatic islets. Bioconjug. Chem. 17(4), 1036-1042 (2006)
184. Weber, L.M., Cheung, C.Y., Anseth, K.S.: Multifunctional pancreatic islet encapsulation barriers achieved via multilayer PEG hydrogels. Cell Transplant. 16(10), 1049-1057 (2007)
185. Abalovich, A.G., Bacque, M.C., Grana, D., Milei, J. (eds). Pig pancreatic islet transplantation into spontaneously diabetic dogs. 22nd International Congress of the TransplantationSociety, Sydney, Australia, 10-14 Aug 2008
186. Koo, S.K., Kim, S.C., Wee, Y.M., Kim, Y.H., Jung, E.J., Choi, M.Y., et al.: Experimental microencapsulation of porcine and rat pancreatic islet cells with air-driven droplet generator and alginate. Transplant. Proc. 40(8), 2578-2580 (2008)
187. Qi, M., Strand, B.L., Morch, Y., Lacik, I., Wang, Y., Salehi, P., et al.: Encapsulation of human islets in novel inhomogeneous alginate-Ca microbeads: In vitro and in vivo function. Artif. Cells Blood Substit.Immobil. Biotechnol. 36(5), 403-420 (2008)
188. de Groot, M., Schuurs, T.A., van Schilfgaarde, R.: Causes of limited survival of microencapsulated pancreatic islet grafts. J. Surg. Res. 121(1), 141-150 (2004)
189. de Groot, M., Schuurs, T.A., van Schilfgaarde, R.: Causes of limited survival of microencapsulated pancreatic islet grafts. J. Surg. Res. 121(1), 141-159 (2005)
190. Zimmermann, H., Shirley, S., Zimmermann, U.: Alginate-based encapsulation of cells: Past, present, and future. Curr. Diab. Rep. 7(4), 314-320 (2007)
191. Strand, B.L., Ryan, L., Veld, P.I., Kulseng, B., Rokstad, A.M., Skjak-Braek, G., et al.: Poly- L-lysine induces fibrosis on alginate microcapsules via the induction of cytokines. Cell Transplant. 10(3), 263-275 (2001)
192. Dionne, K.E., Colton, C.K., Yarmush, M.L.: Effect of hypoxia on insulin-secretion by isolated rate and canine islets of Langerhans. Diabetes 42(1), 12-21 (1993)
193. Matsumoto, S., Qualley, S.A., Rigley, T.H., Marsh, C.L., Stevens, R.B.: Prolonged preservation of the human pancreas prior to islet isolation using the two-layer (University of Wisconsin solution [UW]/perfluorocarbon) method. Transplantation 69(8), 384 (2000)
194. Maillard, E., Sanchez-Dominguez, M., Kleiss, C., Langlois, A., Sencier, M.C., Vodouhe, C., et al.: Perfluorocarbons: New tool for islets preservation in vitro. Transplant. Proc. 40(2), 372-374 (2008)
195. Sigrist, S., Mechine-Neuville, A., Mandes, K., Calenda, V., Braun, S., Legeay, G., et al.: Influence of VEGF on the viability of encapsulated pancreatic rat islets after transplantation in diabetic mice. Cell Transplant. 12(6), 627-635 (2003)
196. Sigrist, S., Mechine-Neuville, A., Mandes, K., Calenda, V., Legeay, G., Bellocq, J.P., et al.: Induction of angiogenesis in omentum with vascular endothelial growth factor: Influence on the viability of encapsulated rat pancreatic islets during transplantation. J. Vasc. Res. 40(4), 359-367 (2003)
197. Lai, Y., Schneider, D., Kidszun, A., Hauck-Schmalenberger, I., Breier, G., Brandhorst, D., et al.: Vascular endothelial growth factor increases functional beta-cell mass by improvement of angiogenesis of isolated human and murine pancreatic islets. Transplantation 79(11), 1530-1536 (2005)
198. Lembert, N., Wesche, J., Petersen, P., Doser, M., Zschocke, P., Becker, H.D., et al.: Encapsulation of islets in rough surface, hydroxymethylated polysulfone capillaries stimulates VEGF release and promotes vascularization after transplantation. Cell Transplant. 14(2), 97-108 (2005)
199. Juang, J., Hsu, B., Kuo, C., Ueng, S.: Beneficial effects of hyperbaric oxygen therapy on islet transplantation. Cell Transplant. 11(2), 95-101 (2002)
200. Lakey, J.R.T., Mirbolooki, M., Shapiro, A.M.J.: Current status of clinical islet cell transplantation. Transplant. Immunol. 333, 47-103 (2006)
201. Salcedo, R., Ponce, M.L., Young, H.A., Wasserman, K., Ward, J.M., Kleinman, H.K., et al.: Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 96(1), 34-40 (2000)
202. Paule, M.F., McColl, S.R., Simeonovic, C.J.: Murine chemokine gene expression in rejecting pig proislet xenografts. Transplant. Proc. 32(5), 1062 (2000)
203. de Vos, P., Hillebrands, J.-L., De Haan, B.J., Strubbe, J.H., Van Schilfgaarde, R.: Efficacy of a prevascularized expanded polytetrafluoroethylene solid support system as a transplantation site for pancreatic islets 1. Transplantation 63(6), 824-830 (1997)
204. Sen, C.: Wound healing essentials: let there be oxygen. Wound Repair Regen. 17(1), 1-18 (2009)
205. Tandara, A.A., Mustoe, T.A.: Oxygen in wound healing - More than a nutrient. World J. Surg. 28(3), 294-300 (2004)
206. Greif, R., Akca, O., Horn, E.-P., Kurz, A., Sessler, D.I.: Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. N. Engl. J. Med. 342(3), 161-167 (2000)
207. Kumari, R., Willing, L.B., Krady, J.K., Vannucci, S.J., Simpson, I.A.: Impaired wound healing after cerebral hypoxia-ischemia in the diabetic mouse. J. Cereb. Blood Flow Metab. 27(4), 710-718 (2006)
208. Distler, O., Distler, J.H.W., Scheid, A., Acker, T., Hirth, A., Rethage, J., et al.: Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ. Res. 95(1), 109-116 (2004)
209. Salaman, R.A., Harding, K.G.: The aetiology and healing rates of chronic leg ulcers. J. Wound Care 4(7), 320-323 (1995)
210. Shai, A., Maibach, H.I.: Wound healing and ulcers of the skin diagnosis and therapy - The practical approach. Springer, Berlin, Heidelberg (2005)
211. McGill, M., Collins, P., Bolton, T., Yue, D.K.: Management of neuropathic ulceration. J. Wound Care 5(2), 52-54 (1996)
212. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention, 2011, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011.
213. Hafner, J., Schaad, I., Schneider, E., Seifert, B., Burg, G., Cassina, P.C.: Leg ulcers in peripheral arterial disease (arterial leg ulcers): Impaired wound healing above the threshold of chronic critical limb ischemia. J. Am. Acad. Dermatol. 43(6), 1001-1008 (2000)
214. Salaman, J.H., Miller, L., Harding, K.G.: Management of foot ulceration in a patient with diabetes mellitus. J. Wound Care 4(10), 443-444 (1995)
215. Lait, M.E., Smith, L.N.: Wound management: a literature review. J. Clin. Nurs. 7(1), 11-17 (1998)
216. Gordillo, G., Roy, S., Khanna, S., Schlanger, R., Khandelwal, S., Phillips, G., et al.: Topical oxygen therapy induces vascular endothelial growth factor expression and improves closure of clinically presented chronic wounds. Clin. Exp. Pharmacol. Physiol. 35(8), 957-964 (2008)
217. Kalliainen, L., Gordillo, G., Schlanger, R., Sen, C.: Topical oxygen as an adjunct to wound healing: a clinical case series. Pathophysiology 9(2), 81-87 (2003)
218. Fries, R., Wallace, W., Roy, S., Kuppusamy, P., Bergdall, V., Gordillo, G., et al.: Dermal excisional wound healing in pigs following treatment with topically applied pure oxygen. Mutat. Res. 579(1), 172-181 (2005)
219. Davis, S., Cazzaniga, A., Ricotti, C., Zalesky, P., Hsu, L., Creech, J., et al.: Topical oxygen emulsion: a novel wound therapy. Arch. Dermatol. 143(10), 1252 (2007)
220. Scadden, D.T.: The stem-cell niche as an entity of action. Nature 441(7097), 1075-1079 (2006)
221. Mohyeldin, A., Garzon-Muvdi, T., Quinones-Hinojosa, A.: Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell 7(2), 150-161 (2010)
222. Engler, A.J., Sen, S., Sweeney, H.L., Discher, D.E.: Matrix elasticity directs stem cell lineage specification. Cell 126(4), 677-689 (2006)
223. Yoshida, Y., Takahashi, K., Okita, K., Ichisaka, T., Yamanaka, S.: Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 5(3), 237-241 (2009)
224. Grayson, W.L., Zhao, F., Izadpanah, R., Bunnell, B., Ma, T.: Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs. J. Cell. Physiol. 207(2), 331-339 (2006)
225. Ma, T., Grayson, W.L., Frohlich, M., Vunjak-Novakovic, G.: Hypoxia and stem cell-based engineering of mesenchymal tissues. Biotechnol. Prog. 25(1), 32-42 (2009)
226. Zhao, F., Veldhuis, J.J., Duan, Y., Yang, Y., Christoforou, N., Ma, T., et al.: Low oxygen tension and synthetic nanogratings improve the uniformity and stemness of human mesenchymal stem cell layer. Mol. Ther. 18(5), 1010-1018 (2010)
227. Simon, M.C., Keith, B.: The role of oxygen availability in embryonic development and stem cell function. Nat. Rev. Mol. Cell Biol. 9(4), 285-296 (2008)
228. Eliasson, P., Jonsson, J.: The hematopoietic stem cell niche: low in oxygen but a nice place to be. J. Cell. Physiol. 222(1), 17-22 (2010)
229. dos Santos, F., Andrade, P.Z., Boura, J.S., Abecasis, M.M., dos Silva, C.L., Cabral, J.M.S.: Ex vivo expansion of human mesenchymal stem cells: A more effective cell proliferation kinetics and metabolism under hypoxia. J. Cell. Physiol. 223(1), 27-35 (2010)
230. Tottey, S., Corselli, M., Jeffries, E.M., Londono, R., Peault, B., Badylak, S.F.: Extracellular matrix degradation products and low-oxygen conditions enhance the regenerative potential of perivascular stem cells. Tissue Eng. Part A 17(1), 37-44 (2011)
231. Cipolleschi, M.G., Dello Sbarba, P., Olivotto, M.: The role of hypoxia in the maintenance of hematopoietic stem cells. Blood 82(7), 2031-2037 (1993)
232. 2distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian Models. Biophys. J. 81(2), 685-696 (2001)
233. Nilsson, S.K., Johnston, H.M., Coverdale, J.A.: Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. Blood 97(8), 2293-2299 (2001)
234. Parmar, K., Mauch, P., Vergilio, J.-A., Sackstein, R., Down, J.D.: Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc. NatlAcad. Sci. USA 104(13), 5431-5436 (2007)
235. Abdollahi, H., Harris, L., Zhang, P., Mcllhenny, S., Srinivas, V., Tulenko, T., et al.: The role of hypoxia in stem cell differentiation and therapeutics. J. Surg. Res. 1(6), 1 (2009)
236. Ivanovic, Z.: Hypoxia or in situ normoxia: The stem cell paradigm. J. Cell. Physiol. 219(2), 271-275 (2009)
237. Raheja, L.F., Genetos, D.C., Yellowley, C.E.: The effect of oxygen tension on the long-term osteogenic differentiation and MMP/TIMP expression of human mesenchymal stem cells. Cells Tissues Organs 191(3), 175-184 (2010)
238. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., et al.: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5), 861-872 (2007)
239. Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., et al.: Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotech. 26(1), 101-106 (2008). doi:10.1038/nbt1374
240. Millman, J.R., Tan, J.H., Colton, C.K.: The effects of low oxygen on self-renewal and differentiation of embryonic stem cells. Curr. Opin. Organ Transplant. 14(6), 694-700 (2009)
241. Ji, A.R., Ku, S.Y., Cho, M.S., Kim, Y.Y., Kim, Y.J., Oh, S.K., et al.: Reactive oxygen species enhance differentiation of human embryonic stem cells into mesendodermal lineage. Exp. Mol. Med. 42(3), 175-186 (2010)
242. Robertson, E.J.: Teratocarcinomas and Embryonic Stem Cells: A Practical Approach. IRL, Oxford (1987)
243. Boiani, M., Eckardt, S., Scholer, H.R., McLaughlin, K.J.: Oct4 distribution and level in mouse clones: consequences for pluripotency. Genes Dev. 16(10), 1209-1219 (2002)
244. Forristal, C.E., Wright, K.L., Hanley, N.A., Oreffo, R.O.C., Houghton, F.D.: Hypoxia inducible factors regulate pluripotency and proliferation in human embryonic stem cells cultured at reduced oxygen tensions. Reproduction 139(1), 85-97 (2010)
245. Takahashi, K., Yamanaka, S.: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4), 663-676 (2006)
246. Boyer, L.A., Lee, T.I., Cole, M.F., Johnstone, S.E., Levine, S.S., Zucker, J.P., et al.: Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122(6), 947-956 (2005)
247. Keith, B., Simon, M.C.: Hypoxia-inducible factors, stem cells, and cancer. Cell 129(3), 465-472 (2007)
248. Gustafsson, M.V., Zheng, X., Pereira, T., Gradin, K., Jin, S., Lundkvist, J., et al.: Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev. Cell 9(5), 617-628 (2005)
249. Panchision, D.M.: The role of oxygen in regulating neural stem cells in development and disease. J. Cell. Physiol. 220(3), 562-568 (2009)
250. Main, H., Lee, K.L., Yang, H., Haapa-Paananen, S., Edgren, H., Jin, S.B., et al.: Interactions between Notch- and hypoxia-induced transcriptomes in embryonic stem cells. Exp. Cell Res. 316(9), 1610-1624 (2010)
251. Zachar, V., Prasad, S., Weli, S., Gabrielsen, A., Petersen, K., Petersen, M., et al.: The effect of human embryonic stem cells (hESCs) long-term normoxic and hypoxic cultures on the maintenance of pluripotency. In Cancer Cell 8(6), 435-437 (2010)
252. Pear, W.S., Simon, M.C.: Lasting longer without oxygen: The influence of hypoxia on Notch signaling. Cancer Cell 8(6), 435-437 (2005)
253. Kirouac, D.C., Zandstra, P.W.: The systematic production of cells for cell therapies. Cell Stem Cell 3(4), 369-381 (2008)
254. Rosova, I., Dao, M., Capoccia, B., Link, D., Nolta, J.A.: Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 26(8), 2173-2182 (2008)
255. Li, Z., Leung, M., Hopper, R., Ellenbogen, R., Zhang, M.: Feeder-free self-renewal of human embryonic stem cells in 3D porous natural polymer scaffolds. Biomaterials 31(3), 404-412 (2010)
256. Leach, J.B., Powell, E.M.: Understanding hypoxic environments: biomaterials approaches to neural stabilization and regeneration after ischemia. In: Biomaterials. Biomaterials as Stem Cell Niche, pp. 247-274. Springer, Berlin Heidelberg (2010)
257. Furth, M.E., Atala, A.: Stem cell sources to treat diabetes. J. Cell. Biochem. 106(4), 507-511 (2009)
258. Holle, A.W., Engler, A.J.: Cell rheology: Stressed-out stem cells. Nat. Mater. 9(1), 4-6 (2010)
259. Siti-Ismail, N., Bishop, A.E., Polak, J.M., Mantalaris, A.: The benefit of human embryonic stem cell encapsulation for prolonged feeder-free maintenance. Biomaterials 29(29), 3946-3952 (2008)
260. Liu, H., Collins, S.F., Suggs, L.J.: Three-dimensional culture for expansion and differentiation of mouse embryonic stem cells. Biomaterials 27(36), 6004-6014 (2006)
261. Fisher, O.Z., Khademhosseini, A., Langer, R., Peppas, N.A.: Bioinspired materials for controlling stem cell fate. Acc. Chem. Res. 43(3), 419-428 (2009)
262. Bratt-Leal, A.M., Carpenedo, R.L., Ungrin, M.D., Zandstra, P.W., McDevitt, T.C.: Incorporation of biomaterials in multicellular aggregates modulates pluripotent stem cell differentiation. Biomaterials 32(1), 48-56 (2011)
263. Hwang, Y.-S., Cho, J., Tay, F., Heng, J.Y.Y., Ho, R., Kazarian, S.G., et al.: The use of murine embryonic stem cells, alginate encapsulation, and rotary microgravity bioreactor in bone tissue engineering. Biomaterials 30(4), 499-507 (2009)
264. Sengupta, S., Park, S.-H., Patel, A., Carn, J., Lee, K., Kaplan, D.L.: Hypoxia and amino acid supplementation synergistically promote the osteogenesis of human mesenchymal stem cells on silk protein scaffolds. Tissue Eng. Part A 16(12), 3623-3634 (2010)
265. Fridley, K.M., Fernandez, I., Li, M.-T.A., Kettlewell, R.B., Roy, K.: Unique differentiation profile of mouse embryonic stem cells in rotary and stirred tank bioreactors. Tissue Eng. Part A 16(11), 3285-3298 (2010)
266. Serra, M., Brito, C., Sousa, M.F.Q., Jensen, J., Tostoes, R., Clemente, J., et al.: Improving expansion of pluripotent human embryonic stem cells in perfused bioreactors through oxygen control. J. Biotechnol. 148(4), 208-215 (2010)
267. Lovett, M., Rockwood, D., Baryshyan, A., Kaplan, D.L.: Simple modular bioreactors for tissue engineering: a system for characterization of oxygen gradients, human mesenchymal stem cell differentiation, and prevascularization. Tissue Eng. Part C Methods 16(6), 1565-1573 (2010)
268. Malda, J., Martens, D.E., Tramper, J., van Blitterswijk, C.A., Riesle, J.: Cartilage tissue engineering: controversy in the effect of oxygen. Crit. Rev. Biotechnol. 23(3), 175-194 (2003)
269. Barbero, A., Grogan, S., Schafer, D., Heberer, M., Mainil-Varlet, P., Martin, I.: Age related changes in human articular chondrocyte yield, proliferation and post-expansion chondrogenic capacity. Osteoarthritis Cartilage 12(6), 476-484 (2004)
270. Kuo, C.K., Li, W.-J., Mauck, R.L., Tuan, R.S.: Cartilage tissue engineering: its potential and uses. Curr. Opin. Rheumatol. 18(1), 64-73 (2006)
271. Grimshaw, M.J., Mason, R.M.: Bovine articular chondrocyte function in vitro depends upon oxygen tension. Osteoarthritis Cartilage 8(5), 386-392 (2000)
272. Chen, J., Wang, C., Lu, S., Wu, J., Guo, X., Duan, C., et al.: In vivo chondrogenesis of adult bone-marrow-derived autologous mesenchymal stem cells. Cell Tissue Res. 319(3), 429-38 (2005)
273. Xu, Y., Malladi, P., Chiou, M., Bekerman, E., Giaccia, A.J., Longaker, M.T.: In vitro expansion of adipose-derived adult stromal cells in hypoxia enhances early chondrogenesis. Tissue Eng. 13(12), 2981-2993 (2007)
274. Poole, A.R., Kojima, T., Yasuda, T., Mwale, F., Kobayashi, M., Laverty, S.: Composition and structure of articular cartilage: A template for tissue repair. Clin. Orthop. Relat. Res. 391, S26-S33 (2001)
275. Schnabel, M., Marlovits, S., Eckhoff, G., Fichtel, I., Gotzen, L., Vecsei, V., et al.: Dedifferentiation-associated changes in morphology and gene expression in primary human articular chondrocytes in cell culture. Osteoarthritis Cartilage 10(1), 62-70 (2002)
276. Lafont, J.E., Talma, S., Murphy, C.L.: Hypoxia-inducible factor 2a is essential for hypoxic induction of the human articular chondrocyte phenotype. Arthritis Rheum. 56(10), 3297-3306 (2007)
277. Domm, C., Sch&ünke, M., Christesen, K., Kurz, B.: Redifferentiation of dedifferentiated bovine articular chondrocytes in alginate culture under low oxygen tension. Osteoarthritis Cartilage 10(1), 13-22 (2002)
278. Domm, C., ScMnke, M., Steinhagen, J., Freitag, S., Kurz, B.: Influence of various alginate brands on the redifferentiation of dedifferentiated bovine articular chondrocytes in alginate bead culture under high and low oxygen tension. Tissue Eng. 10(11), 1796-1805 (2004)
279. Vinatier, C., Mrugala, D., Jorgensen, C., Guicheux, J., Noel, D.: Cartilage engineering: a crucial combination of cells, biomaterials and biofactors. Trends Biotechnol. 27(5), 307-314 (2009)
280. Malladi, P., Xu, Y., Chiou, M., Giaccia, A.J., Longaker, M.T.: Effect of reduced oxygen tension on chondrogenesis and osteogenesis in adipose-derived mesenchymal cells. Am. J. Physiol. Cell Physiol. 290(4), C1139-C1146 (2006)
281. Zscharnack, M., Poesel, C., Galle, J., Bader, A.: Low oxygen expansion improves subsequent chondrogenesis of ovine bone-marrow-derived mesenchymal stem cells in collagen type I hydrogel. Cells Tissues Organs 190(2), 81-93 (2008)
282. Mizuno, S., Glowacki, J.: Low oxygen tension enhances chondroinduction by demineralized bone matrix in human dermal fibroblasts in vitro. Cells Tissues Organs 180(3), 151-158 (2005)
283. Buxton, A.N., Bahney, C.S., Yoo, J.U., Johnstone, B.: Temporal exposure to chondrogenic factors modulates human mesenchymal stem cell chondrogenesis in hydrogels. Tissue Eng. Part A 17(3), 371-380 (2011)
284. Grande, D.A., Breitbart, A.S., Mason, J., Paulino, C., Laser, J., Schwartz, R.E.: Cartilage tissue engineering: Current limitations and solutions. Clin. Orthop. Relat. Res. 367, 176-185 (1999)
285. Mostafa, S.S., Miller, W.M., Papoutsakis, E.T.: Oxygen tension influences the differentiation, maturation and apoptosis of human megakaryocytes. Br. J. Haematol. 111(3), 879-889 (2000)